Search research articles
Contact Us
Filters
Showing results (161-170 of 210) with videos related to
Page
of 21
Sort By:
The Journal of Allergy and Clinical Immunology
|
March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference
Jason Gotlib, Tracy I George, Melody C Carter, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 31, 2024
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
Peter Valent, Karin Hartmann, Gregor Hoermann, et al.
The Journal of Investigative Dermatology
|
February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis
Elisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Nature Medicine
|
December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance
Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Jerald P Radich, Michael Deininger, Camille N Abboud, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
Blood
|
February 29, 2020
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 210) with videos related to
Sort By:
Page
of 21
The Journal of Allergy and Clinical Immunology
|
March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference
Jason Gotlib, Tracy I George, Melody C Carter, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 31, 2024
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
Peter Valent, Karin Hartmann, Gregor Hoermann, et al.
The Journal of Investigative Dermatology
|
February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis
Elisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Nature Medicine
|
December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance
Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Jerald P Radich, Michael Deininger, Camille N Abboud, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
Blood
|
February 29, 2020
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, et al.
Page
of 21